It is reported that Zhejiang medical equipment manufacturing enterprises have more than 1300, there are more than 6000 registered products, medical device companies more than 5700, the use of medical devices, medical institutions have more than 30000.
Innovation creation of traditional industries
Taizhou Zhejiang is the production base of disposable medical equipment, Taizhou Zhejiang food and Drug Supervision Bureau Director Dai Guofu said that the current annual output value of medical devices and equipment industry has exceeded 1800000000 yuan, the syringe and infusion products accounted for more than 15% of the market share in China, accounting for more than 15% of China's market share of equipment has reached more than 300 sterile medical equipment manufacturers in china.
As early as in a few years ago, the disposable medical device industry had experienced the disorderly and low price competition, after a lot of rectification and improvement, "now can insist in disposable medical device entrepreneur is conscientious, is anyone industrialist, many have become industry inventor", Zhejiang Province food and Drug Administration medical device regulatory director Dong Geng to the reporter so said.
Linhai Zhejiang Taizhou Ling Yang Medical Equipment Co., Ltd., in order to produce disposable medical equipment, is in the technological transformation, the workshop in the automation equipment, mainly used for new research and development of products to enhance production, the company's existing patent products are being promoted at home and abroad. Huizhi explain after improvement, the injector only needs some small power will be able to push the barrel forward, especially when used for spinal anesthesia encountered in gas pressure will lead to rebound, let the medical staff judge more easily push pin is in place.
Huizhi said disposable precise filtering transfusion apparatus and pore size of the membrane filtration 4.5 microns to filter the particles more than 5 microns, and human capillary fine about 6 to 8 microns, so can effectively reduce the micro particles entering the human body. If the absorption of excess particles into the blood vessels, clogging capillaries caused cerebral infarction. At present, the industry's national standard is 15 micron.
This is more expensive than ordinary disposable infusion device, the core device in the filter membrane for innovation and improvement.
Enterprise innovation, technological innovation, the original power of the market, but more government guidance, Zhejiang is the implementation of the CPC Zhejiang provincial Party Committee on in-depth study and practice of scientific development concept to accelerate the transformation of economic development mode to promote economic restructuring and upgrading, accelerate industrial restructuring and upgrading, improve the industrial comprehensive strength, international competitiveness and sustainable development capacity, the provincial government issued the Zhejiang Provincial People's Government on accelerating the implementation of industrial restructuring and upgrading, and to develop the implementation of views. Now Zhejiang industrial transformation can be testified in the medical device industry, from the "made in Zhejiang" to "Zhejiang create" again.
Reduce medical expenses
Huizhi said, now Xingaoyi of nuclear magnetic resonance (NMR) series of products also exported to dozens of countries in Middle East, Central Asia, South Korea, India, Russia, Africa, Belarus, Ukraine and other. The localization of the permanent magnetic nuclear magnetic resonance has also indirectly led to the western manufacturers to maintain the profits of the superconducting magnetic resonance.
First, because of permanent magnetic resonance on the human body without injury, the basic inspection in the basic hospital, which is the province of the central and western provinces, in particular, in addition, with the rise of private hospitals, which will become the basic configuration, so the market has increased potential; second, not all diseases need to check the equipment, because the existing approval system for hospital equipment purchase, as the hospital, the purchase of more high-end equipment can understand, but the move also pushed up the cost of medical treatment.
Due to the system or regulations and other factors and the extension of the unreasonable phenomenon is not only in Zhejiang, the chairman of the board of directors to reflect, our new product (Department of orthopedics implantation) into the market due to the relevant provisions in addition to pre testing and other stages, but also through the clinical trial process, and imported products only need to provide proof of origin of the country listed and similar products clinical evaluation information can not be mandatory to do clinical trials." Due to the domestic demand for new products using simple but time-consuming clinical trials link, so that domestic products into the market of the time is greatly increased, which makes the party in face of the competitive pressure from imported products quite helpless.
Zhejiang provincial food and drug supervision and Management Bureau Chief Engineer Su Zhiliang told reporters that the new revised medical device supervision and management regulations have been implemented since June 1st. The regulations is currently the highest legal provisions of China's supervision of medical devices, according to different types of medical devices security risks, set up to strengthen the supervision of high-risk medical devices, release low risk medical devices, and promote medical device product innovation and industry development. Medical device industry is characterized by a wide range of products, the product involved. At present, the State Food and Drug Administration of the relevant supporting regulations and normative documents. And the problem that the square is troubled by, in "new regulations" have the basis that provides the solution. |